5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.66▼ | 1.66▼ | 1.66▼ | 1.72▼ | 1.77▼ |
MA10 | 1.66▼ | 1.66▼ | 1.67▼ | 1.76▼ | 1.81▼ |
MA20 | 1.66▼ | 1.68▼ | 1.70▼ | 1.82▼ | 1.80▼ |
MA50 | 1.66▼ | 1.72▼ | 1.74▼ | 1.87▼ | 2.93▼ |
MA100 | 1.69▼ | 1.75▼ | 1.82▼ | 1.84▼ | 4.36▼ |
MA200 | 1.72▼ | 1.83▼ | 1.80▼ | 2.53▼ | 7.59▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▼ | 0.001▲ | -0.003▼ | -0.021▼ | 0.081▲ |
RSI | 44.865▼ | 36.163▼ | 33.953▼ | 38.864▼ | 38.432▼ |
STOCH | 36.111 | 48.143 | 12.621▼ | 13.318▼ | 25.588 |
WILL %R | -33.333 | -69.231 | -81.818▼ | -95.402▼ | -72.093 |
CCI | -250.407▼ | -135.865▼ | -81.464 | -125.924▼ | -87.681 |
CDL | $NKTX Matching Low Candlestick Pattern Detected | Set Alert |
Friday, June 27, 2025 04:04 AM
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at ...
|
Wednesday, June 25, 2025 04:59 PM
Get the latest Nkarta, Inc. (NKTX) stock news and headlines to help you in your trading and investing decisions.
|
Wednesday, June 25, 2025 04:59 PM
SOUTH SAN FRANCISCO, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
30/06/25 | 1.68 | 1.70 | 1.64 | 1.66 | 505,100 |
27/06/25 | 1.73 | 1.75 | 1.66 | 1.66 | 625,300 |
26/06/25 | 1.79 | 1.79 | 1.70 | 1.73 | 1,031,081 |
25/06/25 | 1.75 | 1.835 | 1.725 | 1.78 | 642,900 |
24/06/25 | 1.76 | 1.805 | 1.73 | 1.75 | 326,600 |
23/06/25 | 1.78 | 1.78 | 1.70 | 1.745 | 420,600 |
20/06/25 | 1.83 | 1.83 | 1.755 | 1.77 | 416,400 |
18/06/25 | 1.79 | 1.84 | 1.77 | 1.82 | 428,168 |
17/06/25 | 1.86 | 1.865 | 1.7904 | 1.81 | 532,573 |
16/06/25 | 1.89 | 1.90 | 1.8206 | 1.89 | 346,862 |
|
|
||||
|
|
||||
|
|